Angewandte
Chemie
[21] R. Y. P. Lue, G. Y. J. Chen, Y. Hu, Q. Zhu, S. Q. Yao, J. Am.
nisms of multivalency in biological interactions and for
biomedical applications in targeted drug delivery, molecular
imaging, and immunology.
Chem. Soc. 2004, 126, 1055.
[22] D. S. Y. Yeo, R. Srinivasan, G. Y. J. Chen, S. Q. Yao, Chem. Eur.
J. 2004, 10, 4664.
[23] J. A. Camarero, Y. Kwon, M. A. Coleman, J. Am. Chem. Soc.
2004, 126, 14730.
[24] T. W. Muir, D. Sondhi, P. A. Cole, Proc. Natl. Acad. Sci. USA
1998, 95, 6705.
Experimental Section
All peptide ligation experiments were performed in
a buffer
containing 0.1m tris(hydroxymethyl)aminomethane (tris), 6m guani-
dine, 2% (v/v)thiophenol, and 2% (v/v) a-toluenethiol (benzyl
mercaptan)pH 7.0–7.5. One equivalent of dendrimers 1, 2, or 3 was
treated with 4, 8, or 16 equivalents of peptide thioester
(ca. 10 mgmLÀ1), respectively, with stirring for 1 h at 378C. The
ligation products were analyzed by LC-MS. All protein-ligation
experiments were performed at 208C in a buffer containing 0.1m
sodium phosphate, 2% (v/v)thiophenol, and 2% (v/v)benzyl
mercaptan pH 7–7.5. Precipitates were removed after the reaction
by centrifugation. 1-(GFP)1 was obtained by ligation of 75 mm GFP
thioester with 2 mm dendrimer 1 for 20 h at 208C. Remaining
dendrimer was removed by repeated concentration and dilution of
the reaction mixture using an Amicon Ultra-4 centrifugal concen-
trator with a 10-kDa cut-off. 1-(GFP)1(GRGDSGG)3 was obtained by
subsequent ligation with 375 mm GRGDSGG-MPAL for 4 h at 208C,
followed by analysis using LC-MS.
[25] R. David, M. P. O. Richter, A. G. Beck-Sickinger, Eur. J.
Biochem. 2004, 271, 663.
[26] A. Borodovsky, H. Ovaa, N. Kolli, T. Gan-Erdene, K. D.
Wilkinson, H. L. Ploegh, B. M. Kessler, Chem. Biol. 2002, 9,
1149.
[27] We have observed similar noncomplete ligation reactions for
small, hydrophobic peptides with limited solubility.
[28] A. J. R. Heck, R. H. H. van den Heuvel, Mass Spectrom. Rev.
2004, 23, 368.
[29] R. H. H. van den Heuvel, A. J. R. Heck, Curr. Opin. Chem. Biol.
2004, 8, 519.
Received: February 21, 2005
Published online: July 11, 2005
Keywords: bioorganic chemistry · dendrimers · multivalency ·
.
peptides · proteins
[1] M. Mammen, S.-K. Choi, G. M. Whitesides, Angew. Chem. 1998,
110, 2908; Angew. Chem. Int. Ed. 1998, 37, 2754.
[2] L. L. Kiessling, L. E. Strong, J. E. Gestwicki, Curr. Opin. Chem.
Biol. 2000, 4, 696.
[3] L. L. Kiessling, L. E. Strong, J. E. Gestwicki, Annu. Rev. Med.
Chem. 2000, 35, 321.
[4] E. Fan, Z. Zhang, W. E. Minke, Z. Hou, C. L. M. J. Verlinde,
W. G. J. Hol, J. Am. Chem. Soc. 2000, 122, 2663.
[5] P. L. Kitov, J. M. Sadowska, G. Mulvey, G. D. Amstrong, H. Ling,
N. S. Pannu, R. J. Read, D. R. Bundle, Nature 2000, 403, 669.
[6] J. Rao, J. Lahiri, L. Isaacs, R. M. Weis, G. M. Whitesides, Science
1998, 280, 708.
[7] A. W. Bosman, H. M. Janssen, E. W. Meijer, Chem. Rev. 1999,
99, 1665.
[8] U. Boas, P. M. H. Heegard, Chem. Soc. Rev. 2004, 33, 43.
[9] J. P. Mitchell, K. D. Roberts, J. Langley, F. Koentgen, J. N.
Lambert, Bioorg. Med. Chem. Lett. 1999, 9, 2785.
[10] J. D. Reuter, A. Myc, M. M. Hayes, Z. Gan, R. Roy, D. Qin, R.
Yin, L. T. Piehler, R. Esfand, D. A. Tomalia, J. R. J. R. Baker,
Bioconjugate Chem. 1999, 10, 271.
[11] I. Vrasidas, N. J. de Mol, R. M. J. Liskamp, R. J. Pieters, Eur. J.
Org. Chem. 2001, 24, 4685.
[12] W. B. Turnbull, J. F. Stoddart, Rev. Mol. Biotechnol. 2002, 90,
231.
[13] C. Rao, J. P. Tam, J. Am. Chem. Soc. 1994, 116, 6975.
[14] K. Sadler, J. P. Tam, Rev. Mol. Biotechnol. 2002, 90, 195.
[15] M. Sakamoto, A. Ueno, H. Mihara, Chem. Commun. 2000, 2000,
1741.
[16] M. Zhou, D. Bentley, I. Ghosh, J. Am. Chem. Soc. 2004, 126, 734.
[17] R. Kluger, J. Zhang, J. Am. Chem. Soc. 2003, 125, 6070.
[18] P. E. Dawson, T. W. Muir, I. Clark-Lewis, S. B. Kent, Science
1994, 266, 776.
[19] T. M. Hackeng, J. H. Griffin, P. E. Dawson, Proc. Natl. Acad. Sci.
USA 1999, 96, 10068.
[20] T. J. Tolbert, C.-H. Wong, J. Am. Chem. Soc. 2000, 122, 5421.
Angew. Chem. Int. Ed. 2005, 44, 5052 –5057
ꢀ 2005 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
5057